Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

46 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
BEX2 is poor prognostic factor and required for cancer stemness in gastric cancer.
Yasumoto A, Fujimori H, Mochizuki M, Shibuya-Takahashi R, Nakamura-Shima M, Shindo N, Yamaguchi K, Fukushi D, Wakui Y, Sugai T, Iwai W, Abue M, Sato I, Satoh K, Katayose Y, Yasuda J, Shibata C, Tamai K. Yasumoto A, et al. Among authors: fukushi d. Biochem Biophys Res Commun. 2023 May 7;655:59-67. doi: 10.1016/j.bbrc.2023.03.025. Epub 2023 Mar 11. Biochem Biophys Res Commun. 2023. PMID: 36933308
Delta-6 desaturase FADS2 is a tumor-promoting factor in cholangiocarcinoma.
Hasegawa K, Fujimori H, Nakatani K, Takahashi M, Izumi Y, Bamba T, Nakamura-Shima M, Shibuya-Takahashi R, Mochizuki M, Wakui Y, Abue M, Iwai W, Fukushi D, Satoh K, Yamaguchi K, Shindo N, Yasuda J, Asano N, Imai T, Asada Y, Katori Y, Tamai K. Hasegawa K, et al. Among authors: fukushi d. Cancer Sci. 2024 Oct;115(10):3346-3357. doi: 10.1111/cas.16306. Epub 2024 Aug 7. Cancer Sci. 2024. PMID: 39113435 Free PMC article.
Treatment strategy after noncurative endoscopic resection for early gastric cancers in patients aged ≥ 85 years: a multicenter retrospective study in a highly aged area of Japan.
Hatta W, Toya Y, Shimada T, Hamada K, Watanabe K, Nakamura J, Fukushi D, Koike T, Shinkai H, Ito H, Matsuhashi T, Fujimori S, Iwai W, Hanabata N, Shiroki T, Sasaki Y, Fujishima Y, Tsuji T, Yorozu H, Yoshimura T, Horikawa Y, Takahashi Y, Takahashi H, Kondo Y, Fujiwara T, Mizugai H, Gonai T, Tatsuta T, Onochi K, Kudara N, Abe K, Ogata Y, Ohira T, Horikawa Y, Ishihata R, Hikichi T, Satoh K, Iijima K, Fukuda S, Matsumoto T, Masamune A; for Tohoku GI Endoscopy Group. Hatta W, et al. Among authors: fukushi d. J Gastroenterol. 2023 Apr;58(4):346-357. doi: 10.1007/s00535-022-01948-7. Epub 2023 Jan 12. J Gastroenterol. 2023. PMID: 36633664
Smoking history and severe atrophic gastritis assessed by pepsinogen are risk factors for the prevalence of synchronous gastric cancers in patients with gastric endoscopic submucosal dissection: a multicenter prospective cohort study.
Hatta W, Koike T, Asonuma S, Okata H, Uno K, Oikawa T, Iwai W, Yonechi M, Fukushi D, Kayaba S, Kikuchi R, Ohyauchi M, Fushiya J, Maejima R, Abe Y, Kawamura M, Honda J, Kondo Y, Dairaku N, Norita K, Watanabe K, Takahashi K, Echigo H, Abe Y, Endo H, Okata T, Hoshi T, Nakamura T, Nakaya N, Iijima K, Masamune A; Tohoku G. I. study group. Hatta W, et al. Among authors: fukushi d. J Gastroenterol. 2023 May;58(5):433-443. doi: 10.1007/s00535-023-01967-y. Epub 2023 Feb 14. J Gastroenterol. 2023. PMID: 36786863
Risk stratification of synchronous gastric cancers including alcohol-related genetic polymorphisms.
Asonuma S, Hatta W, Koike T, Okata H, Uno K, Iwai W, Saito M, Yonechi M, Fukushi D, Kayaba S, Kikuchi R, Ito H, Fushiya J, Maejima R, Abe Y, Kawamura M, Honda J, Kondo Y, Dairaku N, Toda S, Watanabe K, Takahashi K, Echigo H, Abe Y, Endo H, Okata T, Hoshi T, Kinoshita K, Kisoi M, Nakamura T, Nakaya N, Iijima K, Masamune A. Asonuma S, et al. Among authors: fukushi d. J Gastroenterol Hepatol. 2024 Aug;39(8):1554-1562. doi: 10.1111/jgh.16570. Epub 2024 Apr 16. J Gastroenterol Hepatol. 2024. PMID: 38628101
Risk factors and pattern of metastatic recurrence after endoscopic resection with additional treatment for esophageal cancer.
Tanaka I, Hatta W, Koike T, Takahashi S, Shimada T, Hikichi T, Toya Y, Onozato Y, Hamada K, Fukushi D, Watanabe K, Kayaba S, Ito H, Tatsuta T, Oikawa T, Takahashi Y, Kondo Y, Yoshimura T, Shiroki T, Nagino K, Hanabata N, Funakubo A, Ohira T, Nakamura J, Nakamura T, Nakaya N, Iijima K, Matsumoto T, Fukuda S, Masamune A, Hirasawa D. Tanaka I, et al. Among authors: fukushi d. Dis Esophagus. 2024 Oct 28;37(11):doae048. doi: 10.1093/dote/doae048. Dis Esophagus. 2024. PMID: 38869095
Prognostic Benefit of Additional Treatment After Endoscopic Submucosal Dissection for Esophageal Squamous Cell Carcinoma.
Takahashi S, Hatta W, Watanabe K, Koike T, Shimada T, Hikichi T, Toya Y, Tanaka I, Onozato Y, Hamada K, Fukushi D, Watanabe K, Kayaba S, Ito H, Mikami T, Oikawa T, Takahashi Y, Kondo Y, Yoshimura T, Shiroki T, Nagino K, Hanabata N, Funakubo A, Hirasawa D, Ohira T, Nakamura J, Nakamura T, Nakaya N, Matsumoto T, Fukuda S, Masamune A, Iijima K. Takahashi S, et al. Among authors: fukushi d. Dig Dis Sci. 2023 May;68(5):2050-2060. doi: 10.1007/s10620-022-07746-8. Epub 2022 Nov 29. Dig Dis Sci. 2023. PMID: 36445654
Combined assessment of clinical and pathological prognostic factors for deciding treatment strategies for esophageal squamous cell carcinoma invading into the muscularis mucosa or submucosa after endoscopic submucosal dissection.
Shimada T, Hatta W, Takahashi S, Koike T, Ohira T, Hikichi T, Toya Y, Tanaka I, Onozato Y, Hamada K, Fukushi D, Watanabe K, Kayaba S, Ito H, Mikami T, Oikawa T, Takahashi Y, Kondo Y, Yoshimura T, Shiroki T, Nagino K, Hanabata N, Funakubo A, Nakamura J, Matsumoto T, Iijima K, Fukuda S, Masamune A, Ito K; Tohoku GI Endoscopy Group. Shimada T, et al. Among authors: fukushi d. Dig Endosc. 2022 Nov;34(7):1382-1391. doi: 10.1111/den.14378. Epub 2022 Aug 9. Dig Endosc. 2022. PMID: 35702926
46 results